diclofenac has been researched along with 1-aminobenzotriazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hata, T; Kawai, S; Nishida, T; Okamura, H | 1 |
| Ford, KA; Halladay, JS; Hop, CE; Khojasteh, SC; Mukadam, S; Sodhi, JK; Wong, S | 1 |
| Halladay, JS; Sodhi, JK | 1 |
3 other study(ies) available for diclofenac and 1-aminobenzotriazole
| Article | Year |
|---|---|
Removal of diclofenac and mefenamic acid by the white rot fungus Phanerochaete sordida YK-624 and identification of their metabolites after fungal transformation.
Topics: Biodegradation, Environmental; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Diclofenac; Enzyme Inhibitors; Mefenamic Acid; Phanerochaete; Triazoles | 2010 |
1-Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9.
Topics: Binding Sites; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Diclofenac; Female; Humans; In Vitro Techniques; Male; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Protein Binding; Substrate Specificity; Tandem Mass Spectrometry; Time Factors; Triazoles; Warfarin | 2014 |
Case Study 9: Probe-Dependent Binding Explains Lack of CYP2C9 Inactivation by 1-Aminobenzotriazole (ABT).
Topics: Binding Sites; Crystallography, X-Ray; Cytochrome P-450 CYP2C9; Diclofenac; Drug Interactions; Gene Silencing; Humans; Models, Molecular; Molecular Docking Simulation; Protein Conformation; Time Factors; Triazoles; Warfarin | 2021 |